Rigel Pharmaceuticals, Inc. (RIGL) Misses Q2 EPS by 4c

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q2 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c